iShares Health Innovation Active ETF (BMED) is a iShares ETF with a 0.55% expense ratio, 62 holdings and $14MM in net assets. Largest sector: Healthcare (100%).
Fee
0.55%
expense ratio
Net assets
$14MM
Launched
Sep 29, 2020
Holdings
62
as of Oct 22, 2026
Top 10 weight
45.5%
largest ten holdings
Largest sector
Healthcare
100.0%
Yield
30-day SEC 0.36% · TTM 0.24%
as of Sep 30, 2026
Benchmark
—
BMED's holdings are as of Oct 22, 2026.
Healthcare
100.0%
1
XTSLA
BLK CSH FND TREASURY SL AGENCY
5.80%
2
GILD
GILEAD SCIENCES
5.60%
3
DHR
DANAHER
5.26%
4
MRNA
MODERNA
4.99%
5
ABBV
ABBVIE
4.91%
6
TMO
THERMO FISHER SCIENTIFIC
4.32%
7
BIIB
BIOGEN
3.86%
8
IQV
IQVIA
3.79%
9
MTD
METTLER TOLEDO INTERNATIONAL
3.62%
10
VRTX
VERTEX PHARMACEUTICALS
3.35%
11
MRK
MERCK
3.07%
12
EW
EDWARDS LIFESCIENCES
3.02%
13
ROP
ROCHE PS PAR AG
2.87%
14
AMGN
AMGEN
2.54%
15
A
AGILENT TECHNOLOGIES
2.43%
16
WAT
WATERS
2.29%
17
HALO
Halozyme Therapeutics
2.23%
18
DXCM
DEXCOM
2.15%
19
GMAB
GENMAB A/S SP ADR ADR
2.05%
20
ILMN
ILLUMINA
1.90%
21
ARGX
ARGENX
1.72%
22
CRL
CHARLES RIVER LABORATORIES
1.66%
23
PFE
PFIZER
1.58%
24
GALD
Galderma Group AG
1.44%
25
NBIX
Neurocrine Biosciences
1.40%
1–25 of 62
Funds listed by how much of their largest holdings they share with BMED — not a ranking.
Data from iShares; prices and returns from market data. Page updated October 29, 2026. Holdings and figures change over time. For information only — not investment advice.